Health Subcommittee, Energy and Commerce Committee, Intelligence (Permanent Select) Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
National Commission on the COVID-19 Pandemic Act This bill temporarily establishes the National Commission on the COVID-19 Pandemic in the legislative branch to investigate the facts and circumstances regarding the emergence of, spread of, and response to COVID-19. The commission terminates 90 days after it submits a final report of its findings and recommendations.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Advisory bodiesAsiaCardiovascular and respiratory healthChemical and biological weaponsChinaCongressional operations and organizationCongressional oversightDisability and health-based discriminationEmergency medical services and trauma careGovernment studies and investigationsHealth facilities and institutionsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesImmunology and vaccinationInfectious and parasitic diseasesIntelligence activities, surveillance, classified informationInternational organizations and cooperationMedical researchPublic contracts and procurementResearch administration and fundingStrategic materials and reservesWorker safety and healthWorld health
National Commission on the COVID–19 Pandemic Act
USA117th CongressHR-7069| House
| Updated: 3/14/2022
National Commission on the COVID-19 Pandemic Act This bill temporarily establishes the National Commission on the COVID-19 Pandemic in the legislative branch to investigate the facts and circumstances regarding the emergence of, spread of, and response to COVID-19. The commission terminates 90 days after it submits a final report of its findings and recommendations.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Advisory bodiesAsiaCardiovascular and respiratory healthChemical and biological weaponsChinaCongressional operations and organizationCongressional oversightDisability and health-based discriminationEmergency medical services and trauma careGovernment studies and investigationsHealth facilities and institutionsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesImmunology and vaccinationInfectious and parasitic diseasesIntelligence activities, surveillance, classified informationInternational organizations and cooperationMedical researchPublic contracts and procurementResearch administration and fundingStrategic materials and reservesWorker safety and healthWorld health